InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
4
T+90 hit rate
50%
T+90 mean return
-5.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Hanly Ann M., Chief Technology Officer. Officer active across 1 company, notably Vir Biotechnology, Inc.. Cumulatively, 8 disclosures have been recorded. Split: 1 buy · 4 sells. Total volume traded: €270k. Activity tracked since 29 November 2021. The latest transaction was filed on 24 February 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hanly Ann M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
14,168 shares@ US$9.453447.2% of flowCommon StockSEC:0001628280-25-007706:0
2,711 shares@ US$10.0529.4% of flowCommon StockSEC:0001628280-24-014468:0
32,500 shares0Common StockSEC:0001628280-24-006985:0
2,627 shares@ US$22.7720.3% of flowCommon StockSEC:0001209191-23-021853:0
37,500 shares0Common StockSEC:0001209191-23-013006:0
2,627 shares@ US$26.23730.0073% mcap98.6% of flowCommon StockSEC:0001209191-22-021728:0
53,500 shares0Common StockSEC:0001209191-22-012955:0
11.52 shares@ US$43.390.0001% mcap0.7% of flowCommon StockSEC:0001209191-21-067380:0
Canonical exit: 27 Feb 2022 (T+90)
8 of 8 declarations
About Hanly Ann M.
Ann M. Hanly is Chief Technology Officer at Vir Biotechnology, Inc. She is responsible for leading the company's technological initiatives. Her expertise in biotechnology is essential in supporting innovation and the development of new products.
